U.S. News

FDA Authorizes Pfizer Booster Shots for Children Between 5 and 11

BOOSTED

Pfizer said its clinical trial data showed that booster shots produced a strong immune response in the age group.

pfizer_5_to_11_n3bk7l
Joseph Prezioso/AFP via Getty

Got a tip? Send it to The Daily Beast here.